Valuation: Sanofi

Market Cap 8.93TCr 10TCr 8.33TCr 7.65TCr 14TCr 9,78900Cr 15TCr 98TCr 38TCr 4,88200Cr 39TCr 38TCr 16,10100Cr P/E 2026 *
12.2x
P/E 2027 * 10.3x
Enterprise Value 10TCr 12TCr 9.39TCr 8.62TCr 16TCr 11,03600Cr 17TCr 1,10800Cr 43TCr 5,50300Cr 43TCr 43TCr 18,15200Cr EV / Sales 2026 *
2.12x
EV / Sales 2027 * 1.91x
Free-Float
89.21%
Yield 2026 *
5.69%
Yield 2027 * 6.04%
1 day-0.80%
1 week-7.07%
Current month-0.54%
1 month-1.08%
3 months-2.65%
6 months-8.91%
Current year-9.80%
1 week 36
Extreme 36
39.8
1 month 36
Extreme 36
39.8
Current year 35.6
Extreme 35.6
41.8
1 year 35.6
Extreme 35.6
45
3 years 35.6
Extreme 35.6
54.5
5 years 35.6
Extreme 35.6
54.5
10 years 31.4
Extreme 31.4
54.5
Manager TitleAgeSince
Chief Executive Officer 65 01/05/2026
Director of Finance/CFO 64 01/04/2024
Chief Operating Officer 42 01/10/2023
Director TitleAgeSince
Director/Board Member 65 28/04/2020
Chairman 63 25/05/2023
Director/Board Member 57 28/04/2020
Change 5-day change 1-year change 3-year change Capi.($)
-0.80%-7.07% - - 10TCr
+0.05%-7.67%+46.56%+150.73% 1LCr
-1.06%-5.33%+47.63%+49.38% 61TCr
-0.50%-6.77%+24.43%+66.09% 43TCr
+0.60%-2.20%+41.10%+35.75% 35TCr
-0.10%-4.25%+32.02%+40.18% 29TCr
+1.30%-9.71%+4.92%+7.09% 24TCr
+1.74%-8.26%-1.69%-42.03% 21TCr
+0.79%-2.51%+26.92%+57.52% 20TCr
-0.18%-2.24%+14.67%+66.89% 16TCr
Average +0.20%-3.88%+26.28%+47.96% 38.89TCr
Weighted average by Cap. +0.02%-4.34%+33.93%+71.29%

Financials

2026 *2027 *
Net sales 4.75TCr 5.47TCr 4.43TCr 4.07TCr 7.68TCr 5,21000Cr 7.81TCr 52TCr 20TCr 2,59800Cr 21TCr 20TCr 8,56900Cr 5.06TCr 5.82TCr 4.73TCr 4.34TCr 8.18TCr 5,55200Cr 8.32TCr 56TCr 22TCr 2,76900Cr 22TCr 21TCr 9,13200Cr
Net income 771.84Cr 888.09Cr 720.6Cr 661.52Cr 1.25TCr 85TCr 1.27TCr 8.5TCr 3.33TCr 42TCr 3.34TCr 3.26TCr 1,39200Cr 936.4Cr 1.08TCr 874.23Cr 802.56Cr 1.51TCr 1,02700Cr 1.54TCr 10TCr 4.04TCr 51TCr 4.05TCr 3.96TCr 1,68900Cr
Net Debt 1.14TCr 1.31TCr 1.06TCr 974.25Cr 1.84TCr 1,24700Cr 1.87TCr 13TCr 4.9TCr 62TCr 4.91TCr 4.8TCr 2,05100Cr 732.34Cr 842.64Cr 683.72Cr 627.67Cr 1.18TCr 80TCr 1.2TCr 8.06TCr 3.16TCr 40TCr 3.17TCr 3.1TCr 1,32100Cr
Logo Sanofi
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (81.8%): prescription drugs for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases; - human vaccines (18.2%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas. At the end of 2025, the group had 37 production sites worldwide. Net sales are distributed geographically as follows: France (3.9%), Europe (17.1%), the United States (50.8%), China (6%) and other (22.2%).
Employees
74,846
Date Price Change
04/26/04 36.80 -1.60%
03/26/03 €37.40 +1.08%
31/26/31 €37.00 +2.78%
30/26/30 €36.00 -9.55%
29/26/29 €39.80 +0.51%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
74.50EUR
Average target price
94.67EUR
Spread / Average Target
+27.07%

Quarterly revenue - Rate of surprise